NASDAQ:CMRA Comera Life Sciences (CMRA) Stock Forecast, Price & News $0.40 +0.07 (+19.76%) (As of 12:33 PM ET) Add Compare Share Share Today's Range$0.35▼$0.4050-Day Range$0.29▼$0.6852-Week Range$0.26▼$2.17Volume80,573 shsAverage Volume50,286 shsMarket Capitalization$10.87 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Comera Life Sciences (NASDAQ:CMRA) StockComera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. The company's lead pipeline candidate is CLS-001, a subcutaneous formulation of vedolizumab for the treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.Read More CMRA Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CMRA Stock News HeadlinesSeptember 13, 2023 | benzinga.comMassive Insider Trade At Comera Life SciencesSeptember 12, 2023 | benzinga.com10% Owner At This Health Care Company Buys $1.05M of StockSeptember 26, 2023 | Micro-Cap Stock Trader (Ad)Unlock the treasure on Mount Olympus with this little-known mining stock.Investor Find Lithium Gold and Crush the Bear Market with 32k Metric TonsSeptember 12, 2023 | finance.yahoo.comComera Life Sciences Announces the Completion of $4.1 Million Private PlacementAugust 16, 2023 | finance.yahoo.comComera Study Shows Caffeine’s Ability to Reduce Viscosity in AntibodiesAugust 16, 2023 | finance.yahoo.comComera Life Sciences Announces Publication of Study Reinforcing Caffeine’s Viscosity Reducing CapabilitiesAugust 10, 2023 | finance.yahoo.comComera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business HighlightsAugust 8, 2023 | finance.yahoo.comComera Life Sciences Boosts SQore Platform PatentsSeptember 26, 2023 | Micro-Cap Stock Trader (Ad)Unlock the treasure on Mount Olympus with this little-known mining stock.Investor Find Lithium Gold and Crush the Bear Market with 32k Metric TonsAugust 8, 2023 | finance.yahoo.comComera Life Sciences Significantly Expands Intellectual Property Portfolio Strengthening the Proprietary SQore™ PlatformAugust 2, 2023 | finance.yahoo.comComera Life Sciences Announces $4.1 Million Private PlacementAugust 1, 2023 | finance.yahoo.comComera Life Sciences Announces $4.1 Million Private PlacementJuly 24, 2023 | finance.yahoo.comComera Partners with Quality Chemical Laboratories to Strengthen Supply ChainJuly 15, 2023 | seekingalpha.comCMRA Comera Life Sciences Holdings, Inc.May 11, 2023 | finance.yahoo.comComera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business HighlightsMay 11, 2023 | finance.yahoo.comComera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business HighlightsApril 27, 2023 | finance.yahoo.comComera Life Sciences to Participate in Four Upcoming ConferencesApril 3, 2023 | finance.yahoo.comComera Life Sciences Announces Expansion of Patent Portfolio Underlying Core Excipient TechnologyMarch 16, 2023 | msn.comComera Life Sciences GAAP EPS of -$0.18, revenue of $0.15MMarch 16, 2023 | finance.yahoo.comComera Life Sciences Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business HighlightsMarch 16, 2023 | finance.yahoo.comComera Life Sciences Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business HighlightsJanuary 31, 2023 | proactiveinvestors.comComera Life Sciences shares details of recent private placementJanuary 12, 2023 | finance.yahoo.comComera Life Sciences to Present at 22nd Annual PepTalk ConferenceJanuary 5, 2023 | finance.yahoo.comComera Life Sciences to Present at Upcoming Biotech Showcase Investor ConferenceJanuary 4, 2023 | finance.yahoo.comComera Life Sciences Closes $3.6 Million Private Placement Priced At-the-Market under Nasdaq RulesDecember 1, 2022 | uk.finance.yahoo.comComera Life Sciences Holdings, Inc. (NASDAQ:CMRA) insiders are still down US$76k after purchasing last year, recent gain helped regain some lossesNovember 18, 2022 | finance.yahoo.comComera Life Sciences to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor ConferenceSee More Headlines Receive CMRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Comera Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address CMRA Company Calendar Last Earnings8/10/2023Today9/26/2023Next Earnings (Estimated)11/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CMRA CUSIPN/A CIK1907685 Webcomeralifesciences.com Phone617-871-2101FaxN/AEmployees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,000,000.00 Net Margins-906.55% Pretax Margin-903.82% Return on EquityN/A Return on Assets-284.60% Debt Debt-to-Equity RatioN/A Current Ratio0.46 Quick Ratio0.46 Sales & Book Value Annual Sales$630,000.00 Price / Sales14.41 Cash FlowN/A Price / Cash FlowN/A Book Value($0.37) per share Price / Book-0.90Miscellaneous Outstanding Shares27,180,000Free Float24,757,000Market Cap$9.08 million OptionableNot Optionable Beta1.04 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Jeffrey S. Hackman (Age 63)Chairman, Pres & CEO Comp: $400kMr. Michael G. Campbell CPA (Age 54)Exec. VP & CFO Comp: $269.11kDr. Neal I. Muni M.D. (Age 48)MSPH, Exec. VP & COO Comp: $350kDr. David Soane Ph.D.Co-Founder & Member of Scientific Advisory BoardDr. Robert P. Mahoney Ph.D. (Age 59)Chief Scientific Officer Ms. Janice Marie McCourt B.S. (Age 61)CLP, M.B.A., R.Ph., Chief Bus. Officer More ExecutivesKey CompetitorsTrevenaNASDAQ:TRVNApexigenNASDAQ:APGNCyclerion TherapeuticsNASDAQ:CYCNCadrenal TherapeuticsNASDAQ:CVKDCan-Fite BioPharmaNYSE:CANFView All CompetitorsInsidersCharles CheringtonBought 2,053,789 shares on 9/11/2023Total: $1.05 M ($0.51/share)Robert Patrick MahoneyBought 20,000 shares on 8/14/2023Total: $12,600.00 ($0.63/share)David SoaneBought 273,838 shares on 7/31/2023Total: $139,657.38 ($0.51/share)David SoaneBought 202,701 shares on 1/4/2023Total: $249,322.23 ($1.23/share)David SoaneBought 3,000 shares on 11/8/2022Total: $4,140.00 ($1.38/share)View All Insider Transactions CMRA Stock - Frequently Asked Questions How have CMRA shares performed in 2023? Comera Life Sciences' stock was trading at $1.23 at the start of the year. Since then, CMRA shares have decreased by 72.8% and is now trading at $0.3340. View the best growth stocks for 2023 here. Are investors shorting Comera Life Sciences? Comera Life Sciences saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 6,100 shares, a decline of 67.2% from the August 15th total of 18,600 shares. Based on an average daily trading volume, of 69,300 shares, the days-to-cover ratio is presently 0.1 days. Approximately 1.3% of the company's shares are sold short. View Comera Life Sciences' Short Interest. When is Comera Life Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023. View our CMRA earnings forecast. How were Comera Life Sciences' earnings last quarter? Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) released its quarterly earnings results on Thursday, August, 10th. The company reported ($0.08) earnings per share (EPS) for the quarter. The company earned $0.32 million during the quarter. What is Comera Life Sciences' stock symbol? Comera Life Sciences trades on the NASDAQ under the ticker symbol "CMRA." How do I buy shares of Comera Life Sciences? Shares of CMRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Comera Life Sciences' stock price today? One share of CMRA stock can currently be purchased for approximately $0.33. How much money does Comera Life Sciences make? Comera Life Sciences (NASDAQ:CMRA) has a market capitalization of $9.08 million and generates $630,000.00 in revenue each year. The company earns $-18,000,000.00 in net income (profit) each year or ($0.59) on an earnings per share basis. How can I contact Comera Life Sciences? Comera Life Sciences' mailing address is 1395 BRICKELL AVENUE SUITE 800, MIAMI FL, 33131. The official website for the company is comeralifesciences.com. The company can be reached via phone at 617-871-2101 or via email at john.woolford@westwicke.com. This page (NASDAQ:CMRA) was last updated on 9/26/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Comera Life Sciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.